Swiss National Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.6M | Buy |
299,400
+13,900
| +5% | +$1.75M | 0.02% | 493 |
|
|
2025
Q1 | $31.6M | Buy |
285,500
+200
| +0.1% | +$22.1K | 0.02% | 514 |
|
|
2024
Q4 | $38.9M | Sell |
285,300
-13,400
| -4% | -$1.83M | 0.03% | 486 |
|
|
2024
Q3 | $34.4M | Buy |
298,700
+4,100
| +1% | +$472K | 0.02% | 522 |
|
|
2024
Q2 | $40.6M | Buy |
294,600
+400
| +0.1% | +$55.1K | 0.03% | 467 |
|
|
2024
Q1 | $40.6M | Sell |
294,200
-11,100
| -4% | -$1.53M | 0.03% | 478 |
|
|
2023
Q4 | $40.2M | Sell |
305,300
-8,500
| -3% | -$1.12M | 0.03% | 481 |
|
|
2023
Q3 | $35.3M | Sell |
313,800
-38,400
| -11% | -$4.32M | 0.03% | 499 |
|
|
2023
Q2 | $33.2M | Sell |
352,200
-28,300
| -7% | -$2.67M | 0.02% | 551 |
|
|
2023
Q1 | $38.5M | Sell |
380,500
-8,200
| -2% | -$830K | 0.03% | 524 |
|
|
2022
Q4 | $46.4M | Sell |
388,700
-25,527
| -6% | -$3.05M | 0.03% | 463 |
|
|
2022
Q3 | $44M | Buy |
414,227
+1,300
| +0.3% | +$138K | 0.03% | 486 |
|
|
2022
Q2 | $40.3M | Buy |
412,927
+2,100
| +0.5% | +$205K | 0.03% | 517 |
|
|
2022
Q1 | $38.5M | Buy |
410,827
+51,200
| +14% | +$4.8M | 0.02% | 554 |
|
|
2021
Q4 | $30.6M | Sell |
359,627
-13,300
| -4% | -$1.13M | 0.02% | 595 |
|
|
2021
Q3 | $35.8M | Sell |
372,927
-10,100
| -3% | -$969K | 0.02% | 567 |
|
|
2021
Q2 | $37.3M | Buy |
383,027
+42,327
| +12% | +$4.12M | 0.02% | 581 |
|
|
2021
Q1 | $33.1M | Buy |
340,700
+6,100
| +2% | +$593K | 0.02% | 579 |
|
|
2020
Q4 | $32.1M | Sell |
334,600
-8,800
| -3% | -$843K | 0.02% | 562 |
|
|
2020
Q3 | $33M | Sell |
343,400
-3,400
| -1% | -$327K | 0.03% | 516 |
|
|
2020
Q2 | $42.3M | Buy |
346,800
+7,300
| +2% | +$891K | 0.04% | 448 |
|
|
2020
Q1 | $29.4M | Buy |
339,500
+65,200
| +24% | +$5.64M | 0.03% | 469 |
|
|
2019
Q4 | $29.5M | Buy |
274,300
+102,500
| +60% | +$11M | 0.03% | 523 |
|
|
2019
Q3 | $15.5M | Buy |
171,800
+2,900
| +2% | +$261K | 0.02% | 633 |
|
|
2019
Q2 | $14.3M | Buy |
168,900
+3,700
| +2% | +$312K | 0.02% | 662 |
|
|
2019
Q1 | $14.6M | Buy |
165,200
+4,200
| +3% | +$370K | 0.02% | 634 |
|
|
2018
Q4 | $11.5M | Buy |
161,000
+4,500
| +3% | +$321K | 0.01% | 635 |
|
|
2018
Q3 | $19.2M | Hold |
156,500
| – | – | 0.02% | 586 |
|
|
2018
Q2 | $15.4M | Buy |
156,500
+2,800
| +2% | +$275K | 0.02% | 617 |
|
|
2018
Q1 | $12.7M | Buy |
153,700
+3,500
| +2% | +$290K | 0.02% | 644 |
|
|
2017
Q4 | $11.7M | Buy |
150,200
+2,900
| +2% | +$225K | 0.01% | 672 |
|
|
2017
Q3 | $9.03M | Buy |
147,300
+1,900
| +1% | +$116K | 0.01% | 727 |
|
|
2017
Q2 | $6.69M | Buy |
145,400
+1,800
| +1% | +$82.8K | 0.01% | 833 |
|
|
2017
Q1 | $6.22M | Buy |
143,600
+1,000
| +0.7% | +$43.3K | 0.01% | 859 |
|
|
2016
Q4 | $5.52M | Buy |
142,600
+2,400
| +2% | +$92.9K | 0.01% | 896 |
|
|
2016
Q3 | $7.1M | Sell |
140,200
-1,800
| -1% | -$91.2K | 0.01% | 741 |
|
|
2016
Q2 | $6.45M | Hold |
142,000
| – | – | 0.01% | 786 |
|
|
2016
Q1 | $5.42M | Buy |
142,000
+28,800
| +25% | +$1.1M | 0.01% | 838 |
|
|
2015
Q4 | $6.4M | Buy |
113,200
+600
| +0.5% | +$33.9K | 0.02% | 697 |
|
|
2015
Q3 | $4.48M | Buy |
112,600
+15,500
| +16% | +$617K | 0.01% | 839 |
|
|
2015
Q2 | $4.64M | Buy |
97,100
+5,200
| +6% | +$248K | 0.01% | 809 |
|
|
2015
Q1 | $3.65M | Buy |
91,900
+7,900
| +9% | +$314K | 0.01% | 939 |
|
|
2014
Q4 | $1.88M | Buy |
84,000
+2,000
| +2% | +$44.7K | 0.01% | 1304 |
|
|
2014
Q3 | $1.29M | Sell |
82,000
-1,900
| -2% | -$29.8K | ﹤0.01% | 1510 |
|
|
2014
Q2 | $1.25M | Hold |
83,900
| – | – | ﹤0.01% | 1584 |
|
|
2014
Q1 | $1.35M | Buy |
83,900
+24,500
| +41% | +$395K | 0.01% | 1498 |
|
|
2013
Q4 | $555K | Hold |
59,400
| – | – | ﹤0.01% | 1919 |
|
|
2013
Q3 | $672K | Sell |
59,400
-3,000
| -5% | -$33.9K | ﹤0.01% | 1736 |
|
|
2013
Q2 | $835K | Buy |
+62,400
| New | +$835K | ﹤0.01% | 1546 |
|